There were 1,024 press releases posted in the last 24 hours and 241,819 in the last 365 days.

Cold Pain Therapy Market | Projections for the future that would help in taking further strategic steps

PORTLAND, OREGON, UNITED STATE, August 30, 2022 /EINPresswire.com/ -- The cold pain therapy market is expected to grow in upcoming years due to factors such as rise in incidence of injuries in sports and increasing importance of exercise and gym activities. Increase in number of knee and hip surgeries around the world is one of the factors expected to boost the cold pain therapy market growth.

Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/9905

Key benefits of the report:

This study presents the analytical depiction of the global cold pain therapy market along with the current trends and future estimations to determine the investments. The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the market share. The current market is quantitatively analyzed from 2020 to 2027 to highlight the market growth scenario. Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. The report provides a detailed cold pain therapy market analysis based on competitive intensity and how the competition will take shape in coming years. Cold Pain Therapy comprises use of cold materials to relieve the pain. Cold pain therapy is also known as cryotherapy. It reduces the blood flow in a particular area of the body to decrease the inflammation and swelling around the joints. Cold pain therapy is used for relieving the local pain, myofascial pain and pain due to muscle spasm. Ice packs are mostly used as primary analgesics for relieving the pain. They are effective, inexpensive and a drugless method for relieving the pain from sprains, strains and swelling. Injuries which are caused due to sports activities and gym activities are major growth factors for driving the market growth.

Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunity for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future. Considering these factors, COVID -19 is expected to have significant impact on the cold pain therapy market.

Factors such as rise in incidence of sports injuries and increase in importance of gym activities has resulted in growth for the cold pain therapy market over the past years. Growth in number of knee and hip surgeries around the world and need for safe pain management modalities as opposition for oral drug therapy is expected to drive the market growth for cold pain therapy market. Increase in healthcare expenditure due to physical injuries caused due to lack of activity and obesity are some of the factors responsible for the market growth. Initiatives of the government to support the cold pain therapy is expected to flourish the growth of the market. However, factors such as lack of reimbursement, side effects, clinical evidence for medication and therapy and discomfort caused by the treatment is expected to hamper the growth of cold pain therapy market up to some extent over the forecast period. New Product Launch / News:

In April 2019, Pacira BioSciences announced its acquisition with MyoScience, which is expected to advance the non-opioid pain management by adding the FDA-approved iovera system to the Pacira commercial offering. This will help healthcare providers and patients to fight the opioid crisis by offering innovative therapies to decrease or end the need for opioids In 2018, Hisamitsu Pharmaceutical and Olympic and Paralympic Games, Tokyo 2020 signed an agreement to be an official partner to provide external pain relief products during the 2020 Tokyo Olympic and Paralympic Games In June 2018, Halyard Health, Inc. in Alpharetta announced an agreement for acquisition of Cool Systems, Inc., a provider of cold therapy and compression therapy systems. This will help in widening the orthopedic section and would provide innovative non-opioid therapies that decrease or eliminate the usage of opioids for surgical patients.

OTC Products Pharmaceuticals Gels, Ointments and Creams Sprays and Foams Patches Roll-ons Roll-ons Cooling Towels Compresses Wraps Pads Cold packs By Application

Musculoskeletal Disorders Sports Medicine Post-Operative Therapy Post-Trauma Therapy By Therapy

Icepack Therapy Chamber Therapy Cryosurgery

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/9905

We also Offers Regional and Country Reports-

Japan Cold Pain Therapy Market South Korea Cold Pain Therapy Market Singapore Cold Pain Therapy Market China Cold Pain Therapy Market Indonesia Cold Pain Therapy Market Australia Cold Pain Therapy Market Taiwan Cold Pain Therapy Market

Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises.

David Correa Allied Analytics LLP +1 800-792-5285 email us here Visit us on social media: Facebook Twitter LinkedIn

EIN Presswire's priority is source transparency. We do not allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something we have missed, please do bring it to our attention. Your help is welcome. EIN Presswire, Everyone's Internet News Presswire™, tries to define some of the boundaries that are reasonable in today's world. Please see our Editorial Guidelines for more information.

© 1995-2022 Newsmatics Inc. dba EIN Presswire All Right Reserved.